Equities

AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NZD)3.65
  • Today's Change-0.09 / -2.41%
  • Shares traded31.89k
  • 1 Year change-22.01%
  • Beta0.4145
Data delayed at least 20 minutes, as of Jun 23 2022 06:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • AFT:NZC price moved over -2.14% to 3.66
  • AFT:NZC price falls below 50-day moving average to 3.66 at 15:04 BST

Key statistics

On Thursday, AFT Pharmaceuticals Ltd (AFT:NZC) closed at 3.65, 17.74% above the 52 week low of 3.10 set on May 19, 2022.
52-week range
Today
3.10May 19 20225.00Nov 23 2021
Open3.74
High3.74
Low3.65
Bid3.61
Offer3.65
Previous close3.74
Average volume38.30k
Shares outstanding104.87m
Free float27.63m
P/E (TTM)19.10
Market cap382.76m NZD
EPS (TTM)0.1911
NZD
Data delayed at least 20 minutes, as of Jun 23 2022 06:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.